Crystal structure of the catalytic domain of the mitotic checkpoint kinase Mps1 in complex with SP600125

被引:51
作者
Chu, Matthew L. H. [1 ,4 ]
Chavas, Leonard M. G. [2 ,3 ]
Douglas, Kenneth T. [1 ,4 ]
Eyers, Patrick A. [2 ,3 ]
Tabernero, Lydia [2 ,3 ]
机构
[1] Univ Manchester, Sch Pharm & Pharmaceut Sci, Manchester M13 9PT, Lancs, England
[2] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England
[3] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England
[4] Univ Manchester, Sch Pharm & Pharmaceut Sci, Manchester M13 9PT, Lancs, England
基金
英国医学研究理事会;
关键词
D O I
10.1074/jbc.M803026200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Chromosomal instability can result from defective control of checkpoints and is associated with malignant cell growth. Monopolar spindle 1 (Mps1) is a dual-specificity protein kinase that has important roles in the prevention of aneuploidy during the cell cycle and might therefore be a potential target for new therapeutic agents in the treatment of cancer. To gain insights into the molecular mechanism of Mps1 inhibition by small molecules, we determined the x-ray structure of Mps1, both alone and in complex with the ATP-competitive inhibitor SP600125. Mps1 adopts a classic protein kinase fold, with the inhibitor sitting in the ATP-binding site where it is stabilized by hydrophobic interactions. We identified a secondary pocket, not utilized by SP600125, which might be exploited for the rational design of specific Mps1 inhibitors. These structures provide important insights into the interaction of this protein kinase with small molecules and suggest potential mechanisms for Mps1 regulation.
引用
收藏
页码:21495 / 21500
页数:6
相关论文
共 30 条
[1]   Structural basis of Aurora-A activation by TPX2 at the mitotic spindle [J].
Bayliss, R ;
Sardon, T ;
Vernos, I ;
Conti, E .
MOLECULAR CELL, 2003, 12 (04) :851-862
[2]   SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase [J].
Bennett, BL ;
Sasaki, DT ;
Murray, BW ;
O'Leary, EC ;
Sakata, ST ;
Xu, WM ;
Leisten, JC ;
Motiwala, A ;
Pierce, S ;
Satoh, Y ;
Bhagwat, SS ;
Manning, AM ;
Anderson, DW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (24) :13681-13686
[3]   Crystal structure of aurora-2, an oncogenic serine/threonine kinase [J].
Cheetham, GMT ;
Knegtel, RMA ;
Coll, JT ;
Renwick, SB ;
Swenson, L ;
Weber, P ;
Lippke, JA ;
Austen, DA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (45) :42419-42422
[4]   Targeting cell cycle kinases for cancer therapy [J].
de Carcer, Guillermo ;
Perez de Castro, Ignacio ;
Malumbres, Marcos .
CURRENT MEDICINAL CHEMISTRY, 2007, 14 (09) :969-985
[5]   The case for open-source software in drug discovery [J].
DeLano, WL .
DRUG DISCOVERY TODAY, 2005, 10 (03) :213-217
[6]   A small-molecule inhibitor of mpsl blocks the spindle-checkpoint response to a lack of tension on mitotic chromosomes [J].
Dorer, RK ;
Zhong, S ;
Tallarico, JA ;
Wong, WH ;
Mitchison, TJ ;
Murray, AW .
CURRENT BIOLOGY, 2005, 15 (11) :1070-1076
[7]   Coot:: model-building tools for molecular graphics [J].
Emsley, P ;
Cowtan, K .
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 2004, 60 :2126-2132
[8]  
EVANS PR, 1997, JOINT CCP4 ESF EACBM, V33
[9]   A novel mechanism for activation of the protein kinase aurora A [J].
Eyers, PA ;
Erikson, E ;
Chen, LG ;
Maller, JL .
CURRENT BIOLOGY, 2003, 13 (08) :691-697
[10]  
Fisk HA, 2004, CELL CYCLE, V3, P439